Skip to main content
EVMN logo
EVMN
(NYSE)
Evommune, Inc.
$23.72-- (--)
Loading... - Market loading

Evommune, Inc. (EVMN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Evommune, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(11 total ratings in last 90 days)
Medium Confidence:1 Buy/Sell

Average Price Target

$49.00
106.58% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest EVMN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kaveri Pohlman
Clear Street
Strong BuyInitiates
$53.00
Mitchell S. Kapoor
HC Wainwright
Strong BuyMaintains
$65.00 $50.00
Judah Frommer
Morgan Stanley
BuyInitiates Coverage
$54.00
Matt Phipps
William Blair
BuyReiterates
-
Mitchell S. Kapoor
HC Wainwright
Strong BuyMaintains
$35.00 $65.00
Gavin Clark-Gartner
Evercore ISI Group
BuyMaintains
$40.00 $55.00
Martin Auster
Raymond James
BuyReiterates
$40.00
Andreas Argyrides
Oppenheimer
BuyInitiates
$42.00
Andreas Argyrides
Oppenheimer
BuyInitiates
$42.00
Martin Auster
Raymond James
Strong BuyInitiates
$40.00
Mitchell S. Kapoor
HC Wainwright
Strong BuyInitiates
$35.00

Frequently Asked Questions

What is the analyst consensus rating for EVMN?

The analyst consensus rating for EVMN is "Buy" based on 7 analyst recommendations.

What is the average price target for EVMN?

The average 12-month price target for EVMN is $49.00, representing an upside of 106.6% from the current price of $23.72.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.